[ad_1]
President Gitanas Nausėda says he has received confirmation from the head of the European Commission (EC), Ursula von der Lajen, that Lithuania will be able to vaccinate around 70% of the population by the summer. adult population of the country.
The president of the European Commission assured that Lithuania will be able to vaccinate at least 70% in the first and second quarters of this year, that is, practically before the beginning of summer. adult population of the country, since the amount of vaccine that is supplied to us in the first and second trimesters will amount to 4 million. dose, which is much more than we are currently vaccinated, ”said G. Nausėda after the meeting of the European Council (EVS) on Friday.
According to him, 70 percent. Vaccination of the population can be achieved “before the coronation of King Mindaugas.”
G. Nausėda stated that to achieve such a level of vaccination, it will be necessary to ensure that an average of 10,000 people are vaccinated per day in February. people, and in the second quarter of this year, up to 34-35 thousand. people a day.
“In other words, if the vaccination rate slows down during the weekend for one reason or another, we have to compensate for the rest of the days of the week, otherwise the math is relentless,” said the head of state.
He said that vaccination centers are already being established, they will have to be in all regions and in large cities, several.
“In the near future, the most important challenge will no longer be the lack of a vaccine, but the ability to vaccinate our people en masse, so that we can make the best use of our time and fully achieve herd immunity,” the president . said.
G. Nausėda reported that next week the European Medicines Agency will consider the issue of AstraZeneca vaccine, and if vaccination is allowed to start in Lithuania in mid-February, it would be possible to receive this vaccine.
The European Union has so far approved two vaccines against the coronavirus. Last month, the community began vaccinating BionTech and Pfizer, and a Moderna vaccine was approved in early January.
Lithuania buys vaccines against the coronavirus together with other European Union countries from six companies: Moderna, AstraZeneca, Janssen Pharmaceutica NV, Sanofi and GSK, BioNTech and Pfizer and CureVac.
Author Milena Andrukaitytė
